Back to Search Start Over

Predictors of false-positive stroke thrombectomy transfers.

Authors :
Yi J
Zielinski D
Ouyang B
Conners J
Dafer R
Chen M
Source :
Journal of neurointerventional surgery [J Neurointerv Surg] 2017 Sep; Vol. 9 (9), pp. 834-836. Date of Electronic Publication: 2017 Mar 30.
Publication Year :
2017

Abstract

Background: Most patients with large vessel occlusion (LVO) stroke need to be transferred to receive thrombectomy. To save time, the decision to transfer often relies on clinical scales as a surrogate for LVO rather than imaging. However, clinical scales have been associated with high levels of diagnostic error. The aim of this study is to define the susceptibility to overdiagnosis of our current transfer decision process by measuring the rate of non-treatment transfers, the most common reasons for no treatment and potential predictors.<br />Methods: Clinical and transfer data on consecutive patients transferred to a single endovascular capable centre for possible thrombectomy via stroke code activation were retrospectively reviewed. Whether patients underwent the procedure, why they did not undergo the procedure, and other clinical and logistical predictors were recorded. χ <superscript>2</superscript> tests and multivariate logistic regression analysis were performed.<br />Results: From 2015 to 2016, 105/192 transferred patients (54%) did not undergo thrombectomy and the most common reason was absence of a LVO found on CTA after transfer (71/104 (68%)). 14/16 (88%) with a National Institutes of Health Stroke Scale (NIHSS) score <10 did not undergo thrombectomy while 41/78 (52%) with a NIHSS>20 underwent thrombectomy (p<0.001). Helicopter use was associated with no treatment (p=0.004) while arrival within 5 hours was associated with treatment (p<0.001).<br />Conclusions: Clinical scales appear to overdiagnose LVO and may be responsible for the majority of our stroke code transfers not undergoing thrombectomy. Primary stroke centres therefore have reason to develop the capability to rapidly acquire and interpret a CTA in patients with suspected LVO prior to transfer. Such efforts may reduce the costs associated with unnecessary thrombectomy transfers.<br />Competing Interests: Competing interests: MC is a consultant for Genentech, Penumbra, Stryker and Medtronic.<br /> (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.)

Details

Language :
English
ISSN :
1759-8486
Volume :
9
Issue :
9
Database :
MEDLINE
Journal :
Journal of neurointerventional surgery
Publication Type :
Academic Journal
Accession number :
28360354
Full Text :
https://doi.org/10.1136/neurintsurg-2017-013043